RE:RE:RE:RE:RE:RE:RE:RE:RE:Merck USA (MSD) acquires Phase 2 biotech for US$ 10.8 Bln.ONCY has been able to complete patient enrollment in its AWARE-1, BRACELET-1 and GOBLET-1 planned clinical trials notwithstanding the issues of COVID-19 that other companies similarly faced but could not overcome.